tirzepatide and kidney function New Trial Studying for Chronic Disease Tirzepatide and Chronic Kidney Disease:

Although canonically GLP1Rs signal through the stimulatory alpha Gs protein, we find that semaglutide utilizes both Gs- and Gq-signaling pathways in GLP1Rs in the area postrema (AP)the primary site of semaglutide action in the brainto differentially regulate neuronal activation across distinct neuronal clusters

Key Facts The study, published May 28 in Nature Communications, examined the electronic health records of almost 84,000 patients with obesity with an average age of 51 years

Open enrollment plan changes If you know you want tirzepatide coverage and your current plan excludes it, open enrollment is your opportunity to switch

Tirzepatide is generally more stable in solution than semaglutide, but proper technique still matters